Incidence and Risk for Developing Proliferative Diabetic Retinopathy after Photocoagulation for Diabetic Maculopathy

References

• Bek T. Regional morphology and pathophysiology of retinal vascular disease. Prog Retin Eye Res. 2013;36:247–59. doi:10.1016/j.preteyeres.2013.07.002.
   PubMed Web of Science ®Google Scholar
• Krick TW, Bressler NM. Recent clinically relevant highlights from the diabetic retinopathy clinical research network. Curr Opin Ophthalmol. 2018;29(r3):199–205. doi:10.1097/ICU.0000000000000472.
   PubMedGoogle Scholar
• Ferris FL, Davis MD, Aiello LM. Treatment of diabetic retinopathy. N Engl J Med. 1999;341:667–78. doi:10.1056/NEJM199908263410907.
   PubMed Web of Science ®Google Scholar
• El Rami H, Barham R, Sun JK, Silva PS. Evidence-based treatment of diabteic retinopathy. Semin Ophthalmol. 2017;32(1):67–74. doi:10.1080/08820538.2016.1228397.
   PubMed Web of Science ®Google Scholar
• Relhan N, Flynn HW Jr. The early treatment diabetic retinopathy study historical review and relevance to today’s management of diabetic macular edema. Curr Opin Ophthalmol. 2017;28(3):205–12. doi:10.1097/ICU.0000000000000362.
   PubMed Web of Science ®Google Scholar
• Stefánsson E, Machemer R, de Juan E Jr, McCuen BW 2nd, Peterson J. Retinal oxygenation and laser treatment in patients with diabetic retinopathy. Am J Ophthalmol. 1992;113(1):36–38. doi:10.1016/S0002-9394(14)75750-2.
   PubMed Web of Science ®Google Scholar
• Gottfredsdóttir MS, Stefánsson E, Jónasson F, Gíslason I. Retinal vasoconstriction after laser treatment for diabetic macular edema. Am J Ophthalmol. 1993;115(1):64–67. doi:10.1016/S0002-9394(14)73526-3.
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group. Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: early treatment diabetic retinopathy study report no. 3. Int Clin Ophthalmol. 1987;274:254–64.
   Google Scholar
• Bek T. Diabetic retinopathy: a review of the Aarhus approach to studies on epidemiology, computerised grading, and the pathophysiology of the disease. Horm Metab Res. 2005;37(Suppl 1):38–8. doi:10.1055/s-2005-861396.
   Google Scholar
• Jeppesen P, Bek T. The occurrence and causes of registered blindness in diabetes patients in Aarhus County, Denmark. Acta Ophthalmol. 2004;82:526–30.
   Web of Science ®Google Scholar
• Mehlsen J, Erlandsen M, Poulsen PL, Bek T. Identification of independent risk factors for the development of diabetic retinopathy requiring treatment. Acta Ophthalmol. 2011;89(6):515–21. doi:10.1111/j.1755-3768.2009.01742.x.
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. ETDRS Report number 1. Arch Ophthalmol. 1985;103(12):1796–806.
   PubMedGoogle Scholar
• Bek T, Erlandsen M. Visual prognosis after panretinal photocoagulation for proliferative diabetic retinopathy. Acta Ophthalmol. 2006;84(1):16–20. doi:10.1111/j.1600-0420.2005.00574.x.
   Web of Science ®Google Scholar
• Jørgensen C, Bek T. Increasing oxygen saturation in larger retinal vessels after photocoagulation for diabetic retinopathy. Invest Ophthalmol Vis Sci. 2014;55(8):5365–69. doi:10.1167/iovs.14-14811.
   PubMed Web of Science ®Google Scholar
• Klein JP, Logan B, Harhoff M, Andersen PK. Analyzing survival curves at a fixed point in time. Stat Med. 2007;26(24):450519. doi:10.1002/(ISSN)1097-0258.
   Web of Science ®Google Scholar
• Harrell FE. Regression modeling strategies. With applications ot linear models, logistic and ordinal regression and survival analysis. 2nd ed. Heidelberg (Germany): Springer; 2015. p. 26–27.
   Google Scholar
• Mitchell P, Wong TY, Diabetic Macular Edema Treatment Guideline Working Group. Management paradigms for diabetic macular edema. Am J Ophthalmol. 2014;157(3):505–13. doi:10.1016/j.ajo.2013.11.012.
   PubMed Web of Science ®Google Scholar
• Baker CW, Jiang Y, Stone T. Recent advancements in diabetic retinopathy treatment from the diabetic retinopathy clinical research network. Curr Opin Ophthalmol. 2016;27(3):210–16. doi:10.1097/ICU.0000000000000262.
   PubMed Web of Science ®Google Scholar
• Peto T, Chakravarthy U. New findings from diabetic retinopathy clinical research retina network protocol V confirm a role for focal laser photocoagulation or observation for eyes with center-involved diabetic macular edema and good visual acuity: new is not always best. JAMA Ophthalmol. 2019 Jul 29;137:838. doi:10.1001/jamaophthalmol.2019.1876. [ Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care. 1992;15(12):1875–91. doi:10.2337/diacare.15.12.1875.
   PubMed Web of Science ®Google Scholar
• Zander E, Herfurth S, Bohl B, Heinke P, Hermann U, Kohnert KD, Kerner W. Maculopathy in patients with diabetes mellitus type 1 and type 2. Br J Ophthalmol. 2000;84(8):871–76. doi:10.1136/bjo.84.8.871.
   PubMed Web of Science ®Google Scholar
• Mehlsen J, Erlandsen M, Poulsen PL, Bek T. Individualized optimization of the screening interval for diabetic retinopathy: a new model. Acta Ophthalmol. 2012;90(2):109–14. doi:10.1111/j.1755-3768.2010.01882.x.
   PubMed Web of Science ®Google Scholar
• Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev. 2000;16:230–36. doi:10.1002/(ISSN)1520-7560.
   PubMed Web of Science ®Google Scholar
• Hove MN, Kristensen JK, Lauritzen T, Bek T. The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Aarhus County, Denmark. Acta Opthalmol. 2004;82(4):443–48. doi:10.1111/j.1600-0420.2004.00270.x.
   Web of Science ®Google Scholar
• Bek T, Klug SE. Incidence and risk factors for neovascular age-related macular degeneration in the fellow eye. Graefes Arch Clin Exp Ophthalmol. 2018;256(11):2061–68. doi:10.1007/s00417-018-4100-z.
   PubMed Web of Science ®Google Scholar
• Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski J, Bek T, Bruno G, Chen S-J, Dekker J, Fletcher A, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–64. doi:10.2337/dc11-1909.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus. UKPDS69. Arch Ophthalmol. 2004;122:1631–40.
   PubMed Web of Science ®Google Scholar
• Gallego PH, Craig ME, Hing S, Donaghue KC. Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study. BMJ. 2008;337:a918. doi:10.1136/bmj.a918.
   PubMedGoogle Scholar
• Bek T, Jørgensen C. The systemic blood pressure and oxygen saturation in retinal arterioles predict the effect of anti-VEGF treatment in diabetic maculopathy. Invest Ophthalmol Vis Sci. 2016;57(13):5429–34. doi:10.1167/iovs.16-20305.
   PubMed Web of Science ®Google Scholar
• Bek T, Stefánsson E, Hardarson SH. Retinal oxygen saturation is an independent risk factor for the severity of diabetic retinopathy. Br J Ophthalmol. 2018 Oct 18. pii: bjophthalmol-2018-312764. doi:10.1136/bjophthalmol-2018-312764. [ Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Diabetes Control and Complications Trial (DCCT). The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The diabetes and control complications trial. Arch Ophthalmol. 1995;113:36–51. doi:10.1001/archopht.1995.01100010038019.
   PubMedGoogle Scholar
• Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, Matthews DR. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44(2):156–63. doi:10.1007/s001250051594.
   PubMed Web of Science ®Google Scholar